PRCP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.182650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.037200E-01
Normal-vs-Stage2
1.369820E-01
Normal-vs-Stage3
3.652400E-01
Normal-vs-Stage4
3.669800E-01
Stage1-vs-Stage2
8.259600E-01
Stage1-vs-Stage3
8.861600E-01
Stage1-vs-Stage4
6.805000E-01
Stage2-vs-Stage3
9.845800E-01
Stage2-vs-Stage4
8.308800E-01
Stage3-vs-Stage4
8.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.068440E-01
Normal-vs-AfricanAmerican
6.800000E-01
Normal-vs-Asian
5.461700E-02
Caucasian-vs-AfricanAmerican
2.263400E-01
Caucasian-vs-Asian
1.058390E-01
AfricanAmerican-vs-Asian
9.615800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.347800E-02
Normal-vs-Female
2.351400E-01
Male-vs-Female
2.075700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.549000E-01
Normal-vs-Age(41-60Yrs)
2.567600E-01
Normal-vs-Age(61-80Yrs)
8.485500E-02
Normal-vs-Age(81-100Yrs)
2.232200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.393400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.298000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.626800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.663000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.776200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.939400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.448100E-02
Normal-vs-Daily Drinker
4.608000E-02
Normal-vs-Weekly Drinker
1.175220E-01
Normal-vs-Occasional Drinker
9.463700E-02
Normal-vs-Social Drinker
3.030000E-01
Non Drinker-vs-Daily Drinker
6.971400E-01
Non Drinker-vs-Weekly Drinker
8.757200E-01
Non Drinker-vs-Occasional Drinker
7.089600E-01
Non Drinker-vs-Social Drinker
3.766200E-01
Daily Drinker-vs-Weekly Drinker
6.269000E-01
Daily Drinker-vs-Occasional Drinker
4.588800E-01
Daily Drinker-vs-Social Drinker
2.491200E-01
Weekly Drinker-vs-Occasional Drinker
8.634000E-01
Weekly Drinker-vs-Social Drinker
5.407400E-01
Occasional Drinker-vs-Social Drinker
5.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.977400E-01
Normal-vs-Grade 2
9.715400E-01
Normal-vs-Grade 3
9.823000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.933600E-01
Grade 1-vs-Grade 3
7.910400E-01
Grade 1-vs-Grade 4
8.977400E-01
Grade 2-vs-Grade 3
4.741000E-01
Grade 2-vs-Grade 4
9.715400E-01
Grade 3-vs-Grade 4
9.823000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.349350E-01
Normal-vs-NonDiabetic
7.190300E-02
Diabetic-vs-NonDiabetic
4.333200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.715800E-01
Normal-vs-NoPancreatitis
1.089800E-01
Pancreatitis-vs-NoPancreatitis
3.190000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.256500E-02
Normal-vs-N1
1.520000E-01
N0-vs-N1
1.503440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.301400E-03
Normal-vs-TP53-NonMutant
1.876590E-01
TP53-Mutant-vs-TP53-NonMutant
2.079600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
